Shopping Cart
Remove All
Your shopping cart is currently empty
Obiltoxaximab is a monoclonal antibody targeting the free protective antigen (PA) of Bacillus anthracis, used for the treatment of inhalational anthrax caused by Bacillus anthracis.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $198 | - | In Stock | |
| 5 mg | $578 | - | In Stock | |
| 10 mg | $929 | - | In Stock |
| Description | Obiltoxaximab is a monoclonal antibody targeting the free protective antigen (PA) of Bacillus anthracis, used for the treatment of inhalational anthrax caused by Bacillus anthracis. |
| In vivo | Method: Obiltoxaximab was administered as a single intravenous (i.v.) dose of 16 mg/kg to humans, macaques, and rabbits, with an observation period of 70 days. Result: The overall serum exposures of Obiltoxaximab were comparable among humans, macaques, and rabbits.[1] |
| Synonyms | ETI204, ETI 204 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Cas No. | 1351337-07-9 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.